NCT05185011View on ClinicalTrials.gov

Study of the Pharmacokinetics and Safety of TPN171H Tablets in Subjects With Mild ,Moderate Hepatic Insufficiency and Normal Liver Function

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 16, 2021

Primary Completion Date

February 6, 2022

Study Completion Date

February 6, 2022

Conditions

Erectile DysfunctionPulmonary Arterial Hypertension

Interventions

DRUG

TPN171H

10 mg TPN171H tablets，single dose

Trial Locations (1)

Unknown

The First Affiliated Hospital of Jilin University, Changchun

All Listed Sponsors

collaborator

Shanghai Institute of Materia Medica, Chinese Academy of Sciences

OTHER

lead

Vigonvita Life Sciences

INDUSTRY

NCT05185011 - Study of the Pharmacokinetics and Safety of TPN171H Tablets in Subjects With Mild ,Moderate Hepatic Insufficiency and Normal Liver Function | Biotech Hunter | Biotech Hunter